in this issue
Gefitinib for advanced non-small-cell lung cancer and quality of life
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
Early detection of second breast cancers improves prognosis in breast cancer survivors
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)
Meta-analysis of the REAL-2 and ML17032 trials
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma
High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial
Use of chemotherapy at end of life in oncology patients
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer
Dietary vitamin D and cancers of the oral cavity and esophagus
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour
Regional chemotherapy for unresectable primary liver cancer
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy
Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib
Drug-induced thrombocytopenia induced by trastuzumab
Non-small-cell lung cancer
Cetuximab-induced aseptic meningitis
Estrogen concentrations in beef and human hormone-dependent cancers